SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hagberg G.) "

Sökning: WFRF:(Hagberg G.)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Semb, G, et al. (författare)
  • Erratum
  • 2017
  • Ingår i: Journal of plastic surgery and hand surgery. - 2000-6764. ; 51:2, s. 158-158
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  •  
3.
  • Örtqvist, Å., et al. (författare)
  • Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group
  • 1996
  • Ingår i: Chest. - 0012-3692. ; 110:6, s. 1499-1506
  • Tidskriftsartikel (refereegranskat)abstract
    • STUDY OBJECTIVE:Comparison of efficacy and safety of sparfloxacin (Spfx) vs roxithromycin (ROXI) for treatment of community-acquired pneumonia (CAP).DESIGN:Multicenter, double-blind, randomized study.SETTING:Twenty-three university and community hospitals in Scandinavia.PATIENTS:Three hundred four adults (> or = 18 years of age) with CAP treated as outpatients (25%) or inpatients (75%).INTERVENTIONS:Randomization 1:1 to Spfx, 400 mg on day 1, then 200 mg once daily, or ROXI, 150 mg twice daily, 10 to 14 days. Safety and efficacy analyses in intention-to-treat (ITT) and evaluable populations.RESULTS:Three hundred three of 304 patients were included in the ITT and safety analyses and 260 (86%) were evaluable at the end of follow-up. Streptococcus pneumoniae was the cause of pneumonia in 62 (20%) patients (11 with bacteremia), Chlamydia pneumoniae in 40 (13%), and Mycoplasma pneumoniae in 38 (13%) patients. The success rates for Spfx and ROXI at the end of follow-up were 82% and 72%, respectively, in the ITT population, and 94% and 79%, respectively, in the evaluable population. The odds ratio Spfx/ROXI for success was 4.5 (95% confidence interval, 1.9, 10.8) for the evaluable population. Both drugs were, overall, equally safe. GI symptoms were the most common adverse experiences in both groups. Prolongation of QTc, without clinical symptoms, was seen in 3% of Spfx patients and in 1% of ROXI patients, and photosensitivity, mostly mild to moderate, was seen in 5% of the Spfx group.CONCLUSIONS:Oral treatment with Spfx was superior to ROXI for the treatment of moderately severe CAP. Spfx was effective for all isolated pathogens, including S pneumoniae, and may be an alternative for empiric treatment of CAP, especially in areas with a high incidence of beta-lactam-resistant pneumococci.
  •  
4.
  •  
5.
  •  
6.
  • Bill-Axelson, Anna, et al. (författare)
  • Radical prostatectomy versus watchful waiting in localized prostate cancer : the Scandinavian prostate cancer group-4 randomized trial
  • 2008
  • Ingår i: Journal of the National Cancer Institute. - 0027-8874 .- 1460-2105. ; 100:16, s. 1144-54
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The benefit of radical prostatectomy in patients with early prostate cancer has been assessed in only one randomized trial. In 2005, we reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. We now report results after 3 more years of follow-up. METHODS: From October 1, 1989, through February 28, 1999, 695 men with clinically localized prostate cancer were randomly assigned to radical prostatectomy (n = 347) or watchful waiting (n = 348). Follow-up was complete through December 31, 2006, with histopathologic review and blinded evaluation of causes of death. Relative risks (RRs) were estimated using the Cox proportional hazards model. Statistical tests were two-sided. RESULTS: During a median of 10.8 years of follow-up (range = 3 weeks to 17.2 years), 137 men in the surgery group and 156 in the watchful waiting group died (P = .09). For 47 of the 347 men (13.5%) who were randomly assigned to surgery and 68 of the 348 men (19.5%) who were not, death was due to prostate cancer. The difference in cumulative incidence of death due to prostate cancer remained stable after about 10 years of follow-up. At 12 years, 12.5% of the surgery group and 17.9% of the watchful waiting group had died of prostate cancer (difference = 5.4%, 95% confidence interval [CI] = 0.2 to 11.1%), for a relative risk of 0.65 (95% CI = 0.45 to 0.94; P = .03). The difference in cumulative incidence of distant metastases did not increase beyond 10 years of follow-up. At 12 years, 19.3% of men in the surgery group and 26% of men in the watchful waiting group had been diagnosed with distant metastases (difference = 6.7%, 95% CI = 0.2 to 13.2%), for a relative risk of 0.65 (95% CI = 0.47 to 0.88; P = .006). Among men who underwent radical prostatectomy, those with extracapsular tumor growth had 14 times the risk of prostate cancer death as those without it (RR = 14.2, 95% CI = 3.3 to 61.8; P < .001). CONCLUSION: Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.
  •  
7.
  •  
8.
  • Boschloo, G., et al. (författare)
  • A comparative study of a polyene-diphenylaniline dye and Ru(dcbpy)(2)(NCS)(2) in electrolyte-based and solid-state dye-sensitized solar cells
  • 2008
  • Ingår i: Thin Solid Films. - 0040-6090. ; 516:20, s. 7214-7217
  • Tidskriftsartikel (refereegranskat)abstract
    • A small organic sensitizer, the polyene-diphenylaniline dye D5, was compared with the standard sensitizer N719 (Ru(dcbPY)(2)(NCS)(2)) in a dyesensitized solar cell investigation. In solar cells with relatively thin layers of mesoporous TiO2 (< 3 mu m) D5 outperformed N719 because of its high extinction coefficient. D5 showed also better performance than N719 in the case of sensitization of mesoporous ZnO. In solid-state solar cells, where the iodide/triiodide electrolyte was replaced by an amorphous hole conductor (spiro-OMeTAD), D5 gave promising preliminary results. The hole conductivity, observed in monolayers of D5 adsorbed at TiO2, may possibly lead to improved performance in such cells.
  •  
9.
  • Bourguignon, J., et al. (författare)
  • Chiral ditopic receptors. Application to palladium-catalyzed allylic alkylation
  • 2003
  • Ingår i: Tetrahedron. - 0040-4020. ; 59:48, s. 9583-9589
  • Tidskriftsartikel (refereegranskat)abstract
    • Chiral pyridinooxazoline, quinolinooxazoline, bis(oxazolino)pyridine (pybox), and bisoxazoline (box) derivatives containing crown ether residues were prepared. Some of the ligands were assessed in substrate binding studies and in palladium catalyzed allylic alkylations.
  •  
10.
  • Doverhag, Christina, 1979-, et al. (författare)
  • Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice
  • 2008
  • Ingår i: Neurobiology of Disease. - 1095-953X. ; 31:1, s. 133-44
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Inflammation and reactive oxygen species (ROS) are important in the development of perinatal brain injury. The ROS-generating enzyme NADPH oxidase (Nox2) is present in inflammatory cells and contributes to brain injury in adult animal models. HYPOTHESIS: NADPH oxidase contributes to ROS formation and development of injury in the immature brain and inhibition of NADPH oxidase attenuates perinatal brain injury. METHODS: We used animal models of term hypoxia-ischemia (HI) (P9 mice) as well as ibotenate-induced excitotoxic injury (P5 mice) mimicking features of periventricular leukomalacia in preterm infants. In vitro microglia cell cultures were used to investigate NADPH oxidase-dependent ROS formation. In vivo we determined the impact 1) of HI on NADPH oxidase gene expression 2) of genetic (gp91-phox/Nox2 knock-out) and 3) of pharmacological NADPH oxidase inhibition on HI-induced injury and NMDA receptor-mediated excitotoxic injury, respectively. Endpoints were ROS formation, oxidative stress, apoptosis, inflammation and extent of injury. RESULTS: Hypoxia-ischemia increased NADPH oxidase subunits mRNA expression in total brain tissue in vivo. In vitro ibotenate increased NADPH oxidase-dependent formation of reactive oxygen species in microglia. In vivo the inhibition of NADPH oxidase did not reduce the extent of brain injury in any of the animal models. In contrast, the injury was increased by inhibition of NADPH oxidase and genetic inhibition was associated with an increased level of galectin-3 and IL-1beta. CONCLUSION: NADPH oxidase is upregulated after hypoxia-ischemia and activated microglia cells are a possible source of Nox2-derived ROS. In contrast to findings in adult brain, NADPH oxidase does not significantly contribute to the pathogenesis of perinatal brain injury. Results obtained in adult animals cannot be transferred to newborns and inhibition of NADPH oxidase should not be used in attempts to attenuate injury.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (8)
Typ av publikation
tidskriftsartikel (123)
konferensbidrag (12)
bokkapitel (3)
forskningsöversikt (2)
recension (1)
Typ av innehåll
refereegranskat (123)
övrigt vetenskapligt (21)
Författare/redaktör
Hagberg, H (29)
Hagberg, J, (16)
Bergstrom, G, (14)
Hagberg, Henrik, 195 ... (12)
Landegren, U (10)
Enblad, G (9)
visa fler...
Glimelius, B (9)
Langstrom, B (8)
Hagberg, Jan (6)
Bergström, Gunnar, (6)
Berglund, A. (6)
Hagberg, Bo, (6)
Osterborg, A, (5)
Jensen, I, (5)
Hagberg, M (5)
Sundstrom, C, (5)
ASTROM, G, (5)
Långström, B. (5)
Bergh, J, (4)
Birgegard, G (4)
Alexanderson, K, (4)
Hagberg, Lars, 1951- ... (4)
Theorell, T, (4)
Mallard, Carina, 196 ... (4)
Carlson, K (4)
Bergstrom, M (4)
Supramaniam, V. G. (4)
Simonsson, B, (4)
Bengtsson, M (3)
Hagberg, Hans, (3)
Lohela-Karlsson, M, (3)
Gressens, P (3)
Salmi, P, (3)
Linder, J. (3)
Marteinsdottir, I (3)
Hartvig, P (3)
Wang, Xiaoyang, 1965 ... (3)
Baburamani, Ana A (3)
Larsson, R, (3)
Svedberg, P, (3)
Lundin, J (3)
Hagberg, B (3)
Hagberg, S., (3)
Nygren, P. (3)
Gustavsson, A. (3)
Josephson, Malin, (3)
Lagerstrom, M. (3)
Lonnerholm, G, (3)
Vontell, R. (3)
Thornton, C. (3)
visa färre...
Lärosäte
Karolinska Institutet (69)
Uppsala universitet (38)
Göteborgs universitet (31)
Lunds universitet (19)
Örebro universitet (5)
Linköpings universitet (4)
visa fler...
Kungliga Tekniska Högskolan (3)
Stockholms universitet (3)
Umeå universitet (2)
Sveriges Lantbruksuniversitet (2)
Luleå tekniska universitet (1)
Högskolan i Jönköping (1)
Malmö universitet (1)
Högskolan i Halmstad (1)
Linnéuniversitetet (1)
Högskolan i Gävle (1)
Blekinge Tekniska Högskola (1)
Ersta Sköndal Bräcke högskola (1)
Sophiahemmet Högskola (1)
visa färre...
Språk
Engelska (139)
Svenska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (58)
Naturvetenskap (5)
Samhällsvetenskap (4)
Teknik (1)
Lantbruksvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy